^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CD79b CAR-T cell therapy

    i
    Other names: CD79b CAR-T cell therapy, CD79b CAR-T cells
    Associations

    News

    Trials
    Company:
    Shanghai Yake Biotech
    Drug class:
    CD79b-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    4years
    CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma (clinicaltrials.gov)
    P1, N=72, Not yet recruiting, Zhejiang University
    Clinical • New P1 trial • Preclinical • CAR T-Cell Therapy
    |
    CD79B (CD79b Molecule)
    |
    CD79b CAR-T cell therapy